Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug for treating coronary heart disease and extraction method thereof

A technology for coronary heart disease and drugs, applied in the field of drugs for the treatment of coronary heart disease, can solve the problems of no quality control indicators, backward production process, slow absorption, etc.

Active Publication Date: 2011-04-27
TIANJIN TASLY MORDEN TCM RESOURCES
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are ordinary compound Danshen tablets and capsules on the market, but the production technology of ordinary tablets and capsules is backward, the content of active ingredients is low, and there is no quality control index. It needs to be taken orally and absorbed through the gastrointestinal tract, and absorbed after the first-pass effect in the liver. Into the blood, low bioavailability, slow absorption. It is not suitable for the first aid needs of patients with angina pectoris

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug for treating coronary heart disease and extraction method thereof
  • Drug for treating coronary heart disease and extraction method thereof
  • Drug for treating coronary heart disease and extraction method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Embodiment 1 The preparation of the drug drop pill for the treatment of coronary heart disease, each component is made up of the weight percent of active ingredient of medicine in terms of crude drug: Salvia miltiorrhiza 82.87%, Radix Notoginseng 16.21%, Borneol 0.92%;

[0067] Step 1: Extract 3 times the amount of Danshen with 95% ethanol under reflux for 2 hours, filter; add 2 times the amount of 95% ethanol to the dregs, extract under reflux for 1 hour, filter, concentrate the extract under reduced pressure, and dry to obtain 95% alcohol extraction of Salvia miltiorrhiza thing;

[0068] Step 2: add 5 times the amount of 40% ethanol to extract the salvia miltiorrhiza dregs obtained after the alcohol extraction for 1.5 hours, and filter; add 4 times the amount of 50% ethanol to the remaining medicinal residues to extract for 1 hour, filter, and extract Concentrate under pressure and dry. Add water to dissolve to sugar content of 48-52%, add ethanol to make the alcohol ...

Embodiment 2

[0071] Embodiment 2 The preparation of the medicine dripping pill for the treatment of coronary heart disease, each component is made up of the weight percentage of active ingredient of medicine in terms of crude drug: Salvia miltiorrhiza 19.8%, Radix Notoginseng 78.2%, Borneol 2%;

[0072] Step 1, 85% ethanol with 2 times the amount of Danshen, reflux extraction once, 1 hour each time, filter, concentrate the extract under reduced pressure, and dry to obtain 85% ethanol extract of Danshen;

[0073] Step 2: add 5 times the amount of 40% ethanol to extract the salvia miltiorrhiza dregs obtained after the alcohol extraction for 1.5 hours, and filter; add 4 times the amount of 50% ethanol to the remaining medicinal residues to extract for 1 hour, filter, and extract Concentrate under pressure and dry. Add water to dissolve to sugar content of 48-52%, add ethanol to make the alcohol content reach 70%, let it stand for more than 12 hours, separate the supernatant, recover the alcoho...

Embodiment 3

[0076] Embodiment 3 The preparation of the drug drop pill for the treatment of coronary heart disease, each component is composed of the weight percentage of active ingredient of medicine in terms of crude drug: Salvia miltiorrhiza 97%, Panax notoginseng 2%, Borneol 1%;

[0077] Step 1, 5 times the amount of Danshen root in 95% ethanol, reflux extraction 3 times, each time for 3 hours, filter, the extract was concentrated under reduced pressure and dried to obtain 95% alcohol extract of Danshen;

[0078] Step 2: add 5 times the amount of 40% ethanol to extract the salvia miltiorrhiza dregs obtained after the alcohol extraction for 1.5 hours, and filter; add 4 times the amount of 50% ethanol to the remaining medicinal residues to extract for 1 hour, filter, and extract Concentrate under pressure and dry. Add water to dissolve to sugar content of 48-52%, add ethanol to make the alcohol content reach 70%, let it stand for more than 12 hours, separate the supernatant, recover the a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a drug for treating coronary heart disease and an extraction method thereof. The extraction method comprises the following steps: extracting salvia with alcohol; extracting dregs of salvia with alcohol; adding notoginseng to the dregs of salvia; and extracting the mixture with water and the like. The invention has the following advantages: the process route can realize industrialization and the quality is stable and controllable. Relevant experiments show that the drug has the advantages of high curative effect and product purity, good absorbability, stable quality and novel application compared with the prior art, and meanwhile, the preparation method is simple in process, convenient to operate, low in cost and suitable for industrial production.

Description

technical field [0001] The invention relates to a medicine for treating coronary heart disease, which belongs to the field of traditional Chinese medicine. Background technique [0002] With the improvement of living standards, the aging of the world's population and the rejuvenation of the disease population, cardiovascular and cerebrovascular patients are increasing year by year, and have become the second largest disease that endangers human health. Angina pectoris is a clinical syndrome caused by temporary myocardial ischemia and hypoxia, with episodic chest pain or chest discomfort as the main manifestation. Coronary heart disease angina pectoris refers to angina pectoris caused by myocardial ischemia and hypoxia due to coronary artery sclerosis or spasm, accounting for about 90% of angina pectoris patients. [0003] The current methods of treating angina pectoris mainly focus on dilating blood vessels, reducing blood viscosity, anti-platelet aggregation, and anti-coag...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/537A61K9/20A61P9/10A61K31/045
Inventor 刘顺航徐波戚可人刘岩陈红丛德刚赵国辉
Owner TIANJIN TASLY MORDEN TCM RESOURCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com